
Biotechnology Product Developer
Source: genomeweb
Thermo Fisher Scientific Prices $2.5 Billion Offering of Senior Notes on Wednesday
According to the company, the issuance price of the $1 billion senior notes due 2026 with a 5% interest rate was 99.931% of their principal, the issuance price of the $1 billion senior notes due 2029 with a 5% interest rate was 99.772% of their principal, and the issuance price of the $500 million senior notes due 2034 with a 5.2% interest rate was 99.846% of their principal.
The offering is expected to be completed around December 5, subject to customary closing conditions, and the notes will bear interest payable semi-annually.
Thermo Fisher Scientific Inc. stated that the company plans to use the proceeds for general corporate purposes, which may include acquiring companies or businesses, repaying debt and refinancing, working capital, and capital expenditures.
The joint bookrunners of the note are BofA Securities, Morgan Stanley, US Bancorp Investments, and Wells Fargo Securities.


